{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:24:05Z","timestamp":1790717045920,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000555","name":"British Microcirculation Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005973","name":"Dr. Mildred Scheel Stiftung f\u00fcr Krebsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ebiom.2020.102647","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T06:53:15Z","timestamp":1580712795000},"page":"102647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma"],"prefix":"10.1016","volume":"52","author":[{"given":"Anne","family":"Fr\u00f6hlich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Loick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Grace","family":"Bawden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Fietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Diekmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Fr\u00f6hlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Niebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Sirokay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Zarbl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2707-0290","authenticated-orcid":false,"given":"Gerrit H.","family":"Gielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Bootz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Landsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimo","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2020.102647_bib0001","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5483\/BMBRep.2014.47.3.283","article-title":"4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy","volume":"47","author":"Vinay","year":"2014","journal-title":"BMB Rep"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102647_bib0002","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/eji.1830240943","article-title":"Molecular and biological characterization of human 4-1BB and its ligand","volume":"24","author":"Alderson","year":"1994","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102647_bib0003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood-2017-06-741041","article-title":"Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies","volume":"131","author":"Chester","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102647_bib0004","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/intimm\/14.3.275","article-title":"Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells","volume":"14","author":"Futagawa","year":"2002","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102647_bib0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/eji.1830240215","article-title":"4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells","volume":"24","author":"Pollok","year":"1994","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102647_bib0006","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4049\/jimmunol.167.3.1313","article-title":"4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy","volume":"167","author":"Cannons","year":"2001","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102647_bib0007","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/eji.200324278","article-title":"Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo","volume":"34","author":"Dawicki","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ebiom.2020.102647_bib0008","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.immunol.23.021704.115839","article-title":"TNF\/TNFR family members in costimulation of T cell responses","volume":"23","author":"Watts","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102647_bib0009","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood-2006-11-056168","article-title":"Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities","volume":"110","author":"Wolfl","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102647_bib0010","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm1107","article-title":"4-1BB-mediated immunotherapy of rheumatoid arthritis","volume":"10","author":"Seo","year":"2004","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102647_bib0011","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.4049\/jimmunol.180.12.8093","article-title":"ERK-dependent BIM modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo","volume":"180","author":"Sabbagh","year":"2008","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102647_bib0012","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1006\/smim.1998.0157","article-title":"Role of 4-1BB in immune responses","volume":"10","author":"Vinay","year":"1998","journal-title":"Semin Immunol"},{"key":"10.1016\/j.ebiom.2020.102647_bib0013","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-065X.2008.00621.x","article-title":"The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer","volume":"222","author":"Lynch","year":"2008","journal-title":"Immunol Rev"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102647_bib0014","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1158\/1078-0432.CCR-17-1922","article-title":"Phase I study of single-agent utomilumab (PF-05082566), a 4-1BB\/CD137 Agonist, in patients with advanced cancer","volume":"24","author":"Segal","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102647_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1517\/14728222.2016.1091448","article-title":"Therapeutic potential of anti-CD137 (4-1BB) monoclonal antibodies","volume":"20","author":"Vinay","year":"2016","journal-title":"Exp Opin Ther Targets"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102647_bib0016","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4049\/jimmunol.158.6.2600","article-title":"Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death","volume":"158","author":"Hurtado","year":"1997","journal-title":"J Immunol"},{"issue":"13 Supplement","key":"10.1016\/j.ebiom.2020.102647_bib0017","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1158\/1538-7445.AM2017-639","article-title":"Abstract 639: morphological changes in mitochondria induced by CD137 (4-1BB) co-stimulation on CD8 T cells","volume":"77","author":"Labiano","year":"2017","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102647_bib0018","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt0202-143","article-title":"Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB","volume":"20","author":"Maus","year":"2002","journal-title":"Nat Biotechnol"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102647_bib0019","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.4049\/jimmunol.162.9.5037","article-title":"Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal","volume":"162","author":"Takahashi","year":"1999","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102647_bib0020","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00262-011-1075-6","article-title":"Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses","volume":"60","author":"Smith","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ebiom.2020.102647_bib0021","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fonc.2015.00117","article-title":"4-1BB Agonists: multi-Potent potentiators of tumor immunity","volume":"5","author":"Bartkowiak","year":"2015","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102647_bib0022","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1158\/0008-5472.CAN-10-1733","article-title":"Agonist Anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes","volume":"71","author":"Palaz\u00f3n","year":"2011","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102647_bib0023","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1096\/fj.11-201061","article-title":"CD137 on inflamed lymphatic endothelial cells enhances CCL21-guided migration of dendritic cells","volume":"26","author":"Teijeira","year":"2012","journal-title":"FASEB J"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102647_bib0024","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1158\/2159-8290.CD-11-0314","article-title":"The HIF-1\u03b1 hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy","volume":"2","author":"Palaz\u00f3n","year":"2012","journal-title":"Cancer Discov"},{"issue":"24","key":"10.1016\/j.ebiom.2020.102647_bib0025","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1073\/pnas.1506357112","article-title":"Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb","volume":"112","author":"Weigelin","year":"2015","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102647_bib0026","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00262-012-1237-1","article-title":"Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity","volume":"61","author":"Fisher","year":"2012","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102647_bib0027","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102647_bib0028","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","article-title":"Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma","volume":"25","author":"Liu","year":"2019","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102647_bib0029","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.immuni.2016.10.022","article-title":"Epigenomic profiling of human CD4+ T cells supports a linear differentiation model and highlights molecular regulators of memory development","volume":"45","author":"Durek","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102647_bib0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","article-title":"De novo epigenetic programs inhibit PD-1 blockade-mediated t cell rejuvenation","volume":"170","author":"Ghoneim","year":"2017","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102647_bib0031","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.4049\/jimmunol.1301395","article-title":"Global DNA methylation remodeling accompanies CD8 T cell effector function","volume":"191","author":"Scharer","year":"2013","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102647_bib0032","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1288329","article-title":"The immune molecular landscape of the B7 and TNFR immunoregulatory ligand-receptor families in head and neck cancer: a comprehensive overview and the immunotherapeutic implications","volume":"6","author":"Chen","year":"2017","journal-title":"Oncoimmunology"},{"issue":"48","key":"10.1016\/j.ebiom.2020.102647_bib0033","doi-asserted-by":"crossref","first-page":"79943","DOI":"10.18632\/oncotarget.13161","article-title":"PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy","volume":"7","author":"Gevensleben","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102647_bib0034","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1221555","article-title":"Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy","volume":"5","author":"Goltz","year":"2016","journal-title":"Oncoimmunology"},{"issue":"25","key":"10.1016\/j.ebiom.2020.102647_bib0035","doi-asserted-by":"crossref","first-page":"41011","DOI":"10.18632\/oncotarget.17354","article-title":"PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients","volume":"8","author":"Goltz","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102647_bib0036","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1257454","article-title":"PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients","volume":"6","author":"Goltz","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102647_bib0037","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/leu.2016.328","article-title":"PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia","volume":"31","author":"Goltz","year":"2017","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102647_bib0038","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/pcmr.12745","article-title":"PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival","volume":"32","author":"Micevic","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.ebiom.2020.102647_bib0039","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ebiom.2018.01.016","article-title":"PD-1 (PDCD1) promoter methylation is a prognostic factor in patients with diffuse lower-grade gliomas harboring isocitrate dehydrogenase (IDH) mutations","volume":"28","author":"R\u00f6ver","year":"2018","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102647_bib0040","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/epi-2018-0149","article-title":"Clinicopathological, immune and molecular correlates of PD-L2 methylation in gastric adenocarcinomas","volume":"11","author":"Lingohr","year":"2019","journal-title":"Epigenomics"},{"issue":"13","key":"10.1016\/j.ebiom.2020.102647_bib0041","doi-asserted-by":"crossref","first-page":"e96793","DOI":"10.1172\/jci.insight.96793","article-title":"CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients","volume":"3","author":"Goltz","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102647_bib0042","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1158\/1078-0432.CCR-13-0945","article-title":"CD137 accurately identifies and enriches for naturally-occurring tumor-reactive T cells in tumor","volume":"20","author":"Ye","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102647_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00608-2","article-title":"Predictors of responses to immune checkpoint blockade in advanced melanoma","volume":"8","author":"Jacquelot","year":"2017","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102647_bib0044","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102647_bib0045","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102647_bib0046","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102647_bib0047","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/bjc.2014.416","article-title":"PD-1(+) CD8(+) T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients","volume":"111","author":"Wu","year":"2014","journal-title":"Br J Cancer"},{"issue":"21","key":"10.1016\/j.ebiom.2020.102647_bib0048","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","article-title":"Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma","volume":"30","author":"Azimi","year":"2012","journal-title":"J Clin Oncol"},{"issue":"7685","key":"10.1016\/j.ebiom.2020.102647_bib0049","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature25144","article-title":"Effector CD8 T cells dedifferentiate into long-lived memory cells","volume":"552","author":"Youngblood","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102647_bib0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13148-017-0354-2","article-title":"Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression","volume":"9","author":"Marwitz","year":"2017","journal-title":"Clin Epigenetics"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102647_bib0051","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/CJI.0000000000000027","article-title":"4-1BB-based Isolation and expansion of CD8+ T cells specific for self-tumor and non-self-tumor antigens for adoptive T-cell therapy","volume":"37","author":"Choi","year":"2014","journal-title":"J Immunother"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102647_bib0052","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/cimm.1998.1396","article-title":"NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by Anti-4-1BB monoclonal antibodies","volume":"190","author":"Melero","year":"1998","journal-title":"Cell Immunol"},{"issue":"3\u20134","key":"10.1016\/j.ebiom.2020.102647_bib0053","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cytogfr.2008.04.003","article-title":"Immune regulation and control of regulatory T cells by OX40 and 4-1BB","volume":"19","author":"So","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102647_bib0054","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ni.1632","article-title":"Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells","volume":"9","author":"Lee","year":"2008","journal-title":"Nat Immunol"},{"issue":"19","key":"10.1016\/j.ebiom.2020.102647_bib0055","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2017.08.10","article-title":"Predictive factors of response to immunotherapy\u2014a review from the Spanish Melanoma Group (GEM)","volume":"5","author":"Espinosa","year":"2017","journal-title":"Ann Transl Med"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102647_bib0056","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s00109-006-0072-2","article-title":"Dual immunoregulatory pathways of 4-1BB signaling","volume":"84","author":"Vinay","year":"2006","journal-title":"J Mol Med"},{"issue":"18","key":"10.1016\/j.ebiom.2020.102647_bib0057","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1158\/1078-0432.CCR-17-1243","article-title":"Phase IB study of utomilumab (PF-05082566), a 4-1BB\/CD137 agonist, in combination with pembrolizumab (MK-3475) in patients with advanced solid tumors","volume":"23","author":"Tolcher","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102647_bib0058","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1002\/cam4.1700","article-title":"Interferon gamma in cancer immunotherapy","volume":"7","author":"Ni","year":"2018","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102647_bib0059","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3\u2013related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102647_bib0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/2326-6066.CIR-17-0159","article-title":"CD137 (4-1BB) costimulation modifies DNA methylation in CD8+ T cell-relevant genes","volume":"6","author":"Aznar","year":"2018","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102647_bib0061","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102647_bib0062","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/2159-8290.CD-13-0440","article-title":"Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis","volume":"4","author":"Parmenter","year":"2014","journal-title":"Cancer Discov"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102647_bib0063","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/ng1834","article-title":"CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer","volume":"38","author":"Weisenberger","year":"2006","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102647_bib0064","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygeno.2015.09.004","article-title":"The DNA methylation landscape of human melanoma","volume":"106","author":"Jin","year":"2015","journal-title":"Genomics"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102647_bib0065","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1158\/1535-7163.MCT-14-0290","article-title":"Effects of BRAF mutations and BRAF inhibition on immune responses to melanoma","volume":"13","author":"Ilieva","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102647_bib0066","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1101\/gad.294991.116","article-title":"Mutant IDH1 regulates the tumor-associated immune system in gliomas","volume":"31","author":"Amankulor","year":"2017","journal-title":"Genes Dev"},{"key":"10.1016\/j.ebiom.2020.102647_bib0067","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1186\/1471-2164-15-997","article-title":"Characterization of age signatures of DNA methylation in normal and cancer tissues from multiple studies","volume":"15","author":"Kim","year":"2014","journal-title":"BMC Genom"},{"key":"10.1016\/j.ebiom.2020.102647_bib0068","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.1038\/ncomms9570","article-title":"The transcriptional landscape of age in human peripheral blood","volume":"6","author":"Peters","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2020.102647_bib0069","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13148-015-0064-6","article-title":"Age-associated DNA methylation changes in immune genes, histone modifiers and chromatin remodeling factors within 5 years after birth in human blood leukocytes","volume":"7","author":"Acevedo","year":"2015","journal-title":"Clin Epigenetics"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102647_bib0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2217\/epi-2016-0143","article-title":"Age-associated DNA methylation changes in naive CD4+ T cells suggest an evolving autoimmune epigenotype in aging T cells","volume":"9","author":"Dozmorov","year":"2017","journal-title":"Epigenomics"},{"key":"10.1016\/j.ebiom.2020.102647_bib0071","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1038\/srep13107","article-title":"Age-related profiling of DNA methylation in CD8+ T cells reveals changes in immune response and transcriptional regulator genes","volume":"5","author":"Tserel","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102647_bib0072","doi-asserted-by":"crossref","first-page":"9648","DOI":"10.1007\/s11357-014-9648-x","article-title":"Genome-wide age-related changes in DNA methylation and gene expression in human PBMCs","volume":"36","author":"Steegenga","year":"2014","journal-title":"Age"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102647_bib0073","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102647_bib0074","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.celrep.2018.03.086","article-title":"Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images","volume":"23","author":"Saltz","year":"2018","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102647_bib0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102647_bib0076","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"10.1016\/j.ebiom.2020.102647_bib0077","first-page":"D991","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102647_bib0078","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/hmg\/ddt420","article-title":"Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis","volume":"23","author":"Marzese","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2020.102647_bib0079","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3389\/fonc.2018.00675","article-title":"Gene expression and methylation analysis in melanomas and melanocytes from the same patient: loss of NPM2 expression is a potential immunohistochemical marker for melanoma","volume":"8","author":"Fujiwara","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.ebiom.2020.102647_bib0080","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-016-1050-x","article-title":"Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus","volume":"18","author":"Zhu","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102647_bib0081","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/15592294.2015.1084462","article-title":"Integrative analysis of methylome and transcriptome in human blood identifies extensive sex- and immune cell-specific differentially methylated regions","volume":"10","author":"Mamrut","year":"2015","journal-title":"Epigenetics"},{"key":"10.1016\/j.ebiom.2020.102647_bib0082","doi-asserted-by":"crossref","first-page":"13507","DOI":"10.1038\/ncomms13507","article-title":"Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease","volume":"7","author":"Ventham","year":"2016","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102647_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003678","article-title":"Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations","volume":"9","author":"Absher","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ebiom.2020.102647_bib0084","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.ebiom.2020.102647_bib0085","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/1471-2105-11-587","article-title":"Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis","volume":"11","author":"Du","year":"2010","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.ebiom.2020.102647_bib0086","first-page":"207","article-title":"Real-time PCR-based assay for quantitative determination of methylation status","volume":"287","author":"Lehmann","year":"2004","journal-title":"Methods Mol Biol"},{"issue":"D1","key":"10.1016\/j.ebiom.2020.102647_bib0087","doi-asserted-by":"crossref","first-page":"D754","DOI":"10.1093\/nar\/gkx1098","article-title":"Ensembl 2018","volume":"46","author":"Zerbino","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2020.102647_bib0088","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/7651_2015_260","article-title":"Bisulfite conversion of DNA from tissues, cell lines, buffy coat, FFPE tissues, microdissected cells, swabs, sputum, aspirates, lavages, effusions, plasma, serum, and urine","volume":"1589","author":"Jung","year":"2017","journal-title":"Methods Mol Biol"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420300220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420300220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:59:04Z","timestamp":1762455544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420300220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":88,"alternative-id":["S2352396420300220"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102647","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102647"}}